Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

29 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Residual phenotypic susceptibility to doravirine in multidrug-resistant HIV-1 from subjects enrolled in the PRESTIGIO Registry.
Saladini F, Giammarino F, Maggiolo F, Ferrara M, Cenderello G, Celesia BM, Martellotta F, Spagnuolo V, Corbelli GM, Gianotti N, Santoro MM, Rusconi S, Zazzi M, Castagna A; PRESTIGIO Study Group. Saladini F, et al. Among authors: corbelli gm. Int J Antimicrob Agents. 2023 Mar;61(3):106737. doi: 10.1016/j.ijantimicag.2023.106737. Epub 2023 Jan 25. Int J Antimicrob Agents. 2023. PMID: 36708743
Burden of Disease in PWH Harboring a Multidrug-Resistant Virus: Data From the PRESTIGIO Registry.
Galli L, Parisi MR, Poli A, Menozzi M, Fiscon M, Garlassi E, Francisci D, Di Biagio A, Sterrantino G, Fornabaio C, Degli Antoni A, Angarano G, Fusco FM, D'Arminio Monforte A, Corbelli GM, Santoro MM, Zazzi M, Castagna A; PRESTIGIO Study Group. Galli L, et al. Among authors: corbelli gm. Open Forum Infect Dis. 2020 Sep 26;7(11):ofaa456. doi: 10.1093/ofid/ofaa456. eCollection 2020 Nov. Open Forum Infect Dis. 2020. PMID: 33241063 Free PMC article.
Long-Term Benefits from Early Antiretroviral Therapy Initiation in HIV Infection.
Lundgren JD, Babiker AG, Sharma S, Grund B, Phillips AN, Matthews G, Kan VL, Aagaard B, Abo I, Alston B, Arenas-Pinto A, Avihingsanon A, Badal-Faesen S, Brites C, Carey C, Casseb J, Clarke A, Collins S, Corbelli GM, Dao S, Denning ET, Emery S, Eriobu N, Florence E, Furrer H, Fätkenheuer G, Gerstoft J, Gisslén M, Goodall K, Henry K, Horban A, Hoy J, Hudson F, Azwa RISR, Kedem E, Kelleher A, Kityo C, Klingman K, Rosa A, Leturque N, Lifson AR, Losso M, Lutaakome J, Madero JS, Mallon P, Mansinho K, Filali KME, Molina JM, Murray DD, Nagalingeswaran K, Nozza S, Ormaasen V, Paredes R, Peireira LC, Pillay S, Polizzotto MN, Raben D, Rieger A, Sanchez A, Schechter M, Sedlacek D, Staub T, Touloumi G, Turner M, Madruga JV, Vjecha M, Wolff M, Wood R, Zilmer K, Lane HC, Neaton JD; INSIGHT Strategic Timing of AntiRetroviral Treatment (START) Study Group. Lundgren JD, et al. Among authors: corbelli gm. NEJM Evid. 2023 Mar;2(3):10.1056/evidoa2200302. doi: 10.1056/evidoa2200302. Epub 2023 Feb 27. NEJM Evid. 2023. PMID: 37213438 Free PMC article.
Preferences of PLWH and of clinicians for HIV treatment aimed at long-term success.
Andreoni M, Antinori A, Castagna A, D'Arminio Monforte A, Di Perri G, Mastroianni C, Mussini C, Rizzardini G, Tavio M, Nozza S, Teti E, Corbelli GM, Pasqualetti P. Andreoni M, et al. Among authors: corbelli gm. New Microbiol. 2022 Dec;45(4):308-319. New Microbiol. 2022. PMID: 36538295 Free article.
PrEP in the Context of Other HIV Risk Reduction Strategies Among Men Who Have Sex with Men: Results from the Flash! PrEP in Europe Survey.
Di Ciaccio M, Delabre RM, Vilotitch A, Corbelli GM, Villes V, Ros Sánchez A, Zantkuijl P, Sweers H, Sanchez F, Meulbroek M, Cairns G, Bernier A, Ghosn J, Carvalho Rocha LM, Cosmaro ML, Duken SB, Dan M, Schlegel V, Stranz R, Jonas KJ, Spire B, Rojas Castro D. Di Ciaccio M, et al. Among authors: corbelli gm. Arch Sex Behav. 2022 Jul;51(5):2451-2464. doi: 10.1007/s10508-022-02322-7. Epub 2022 Jun 20. Arch Sex Behav. 2022. PMID: 35725849 Free PMC article.
Clostridioides difficile infection in solid organ and hematopoietic stem cell transplant recipients: A prospective multinational study.
Blumberg EA, Collins G, Young JH, Nguyen MH, Michonneau D, Temesgen Z, Origȕen J, Barcan L, Obeid KM, Belloso WH, Gras J, Corbelli GM, Neaton JD, Lundgren J, Snydman DR, Molina JM; INSIGHT Clostridioides difficile Study Group. Blumberg EA, et al. Among authors: corbelli gm. Transpl Infect Dis. 2022 Feb;24(1):e13770. doi: 10.1111/tid.13770. Epub 2021 Dec 13. Transpl Infect Dis. 2022. PMID: 34821423
Correction to: Physical, Emotional, and Psychosocial Challenges Associated with Daily Dosing of HIV Medications and Their Impact on Indicators of Quality of Life: Findings from the Positive Perspectives Study.
de Los Rios P, Okoli C, Castellanos E, Allan B, Young B, Brough G, Muchenje M, Eremin A, Corbelli GM, McBritton M, Hardy WD, Van de Velde N. de Los Rios P, et al. Among authors: corbelli gm. AIDS Behav. 2021 Sep;25(9):3045. doi: 10.1007/s10461-021-03206-y. AIDS Behav. 2021. PMID: 33709213 Free PMC article. No abstract available.
Regional differences in perceived treatments needs and priorities in relation to antiretroviral therapy among people living with HIV in 25 countries.
Okoli C, Van de Velde N, Allan B, Hardy WD, Corbelli GM, Muchenje M, Castellanos E, Brough G, Young B, Eremin A, Ramothwala P, McBritton M, de Los Rios P. Okoli C, et al. Among authors: corbelli gm. Prev Med. 2021 Jan;142:106372. doi: 10.1016/j.ypmed.2020.106372. Epub 2020 Dec 24. Prev Med. 2021. PMID: 33333128 Free article.
Physical, Emotional, and Psychosocial Challenges Associated with Daily Dosing of HIV Medications and Their Impact on Indicators of Quality of Life: Findings from the Positive Perspectives Study.
de Los Rios P, Okoli C, Castellanos E, Allan B, Young B, Brough G, Muchenje M, Eremin A, Corbelli GM, McBritton M, Hardy WD, Van de Velde N. de Los Rios P, et al. Among authors: corbelli gm. AIDS Behav. 2021 Mar;25(3):961-972. doi: 10.1007/s10461-020-03055-1. Epub 2020 Oct 7. AIDS Behav. 2021. PMID: 33026574 Free PMC article.
29 results